{
  "ptid_time": "023_S_0042_2011-04-13",
  "img_path": "/data/qiuhui/data/adni/images/023_S_0042/2011-04-13/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 63,866 mm³, 65.8% above the reference mean. With a Z-score of 1.58 (94.3th percentile), this represents moderate enlargement; hippocampal volume measures 3,515 mm³, 53.5% below the reference mean. With a Z-score of -5.22 (0.0th percentile), this represents profound atrophy; whole brain volume measures 888,396 mm³, 17.7% below the reference mean. With a Z-score of -2.30 (1.1th percentile), this represents significant atrophy; entorhinal cortex volume measures 2,356 mm³, 42.5% below the reference mean. With a Z-score of -2.89 (0.2th percentile), this represents significant atrophy; fusiform gyrus volume measures 14,160 mm³, 24.8% below the reference mean. With a Z-score of -2.12 (1.7th percentile), this represents significant atrophy; middle temporal gyrus volume measures 15,272 mm³, 28.4% below the reference mean. With a Z-score of -2.56 (0.5th percentile), this represents significant atrophy. ",
  "text_data": "Age is 77.8 years. Gender is Male. Education: 18 years. Handedness: Right. Race: White. Medical history: Endocrine-Metabolic; Allergies or Drug Sensitivities; Alcohol Abuse; Smoking; Major Surgical Procedures. MMSE: 23.0. MoCA: 19.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.02 SUVR (normal ); Amyloid beta: 1483.00 pg/mL (mild elevated); Total tau: 238.80 pg/mL (normal ); Phosphorylated tau: 19.56 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound hippocampal atrophy (Z-score -5.22) and significant atrophy in multiple brain regions (whole brain, entorhinal cortex, fusiform gyrus, middle temporal gyrus), alongside moderate ventricular enlargement. Cognitive testing (MMSE 23, MoCA 19) indicates mild impairment, while biomarkers show mild Aβ elevation but normal tau and AV45.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amnestic subtype due to hippocampal atrophy, but not yet meeting full dementia criteria).  \n\n**Confidence:** **Medium** (cognitive scores are borderline, and while structural atrophy is severe, biomarker profile is not strongly AD-typical).  \n\n*Note:* If progressive decline is documented clinically, progression to **dementia (likely Alzheimer’s disease)** would be expected. Re-evaluation with longitudinal cognitive/imaging data would increase confidence.",
  "timestamp": "2025-07-26T02:29:02.864338"
}